DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 050576
NDA 050576 describes NILSTAT, which is a drug marketed by Lederle, Dava Pharms Inc, and Glenmark Generics, and is included in six NDAs. Additional details are available on the NILSTAT profile page.
The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 050576
| Tradename: | NILSTAT |
| Applicant: | Dava Pharms Inc |
| Ingredient: | nystatin |
| Patents: | 0 |
| Therapeutic Class: | Antifungals |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 050576
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;ORAL | Strength | 100% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | ||||
| Approval Date: | Dec 22, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
